Wave Life Sciences Ltd. - Director's Dealing 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Wave Life Sciences Ltd. (WVE)
CIK: 0001631574
Period of Report: 2019-08-05

Reporting Person: Baldry Mark (Chief Commerical Officer)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-05	Ordinary Shares	A	35000	$0.00	Acquired	35000	Direct
2019-08-05	Ordinary Shares	A	4000	$0.00	Acquired	39000	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-08-05	Share Option (right to buy)	$19.48	A	25000	Acquired	2029-08-05	Ordinary Shares (25000)	Direct

F1: Consists of restricted share units (RSUs). The RSUs vest in four equal annual installments of 25% on August 5, 2020 through August 5, 2023.

F2: Consists of RSUs. The RSUs vest as to 50% on August 5, 2020 and 50% on August 5, 2021.

F3: The option vests as to 25% of the shares on August 5, 2020 and the remainder vests quarterly thereafter until August 5, 2023.